معرفی
Ingrid Hopper is an Associate Professor at Monash University’s Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, and a consultant physician at the Alfred Hospital. She is affiliated with the Victorian Heart Institute (VHI) and actively contributes to national and international research in clinical pharmacology and cardiovascular therapeutics.
- Academic Appointment: Associate Professor, Department of Epidemiology and Preventive Medicine, Monash University
- Clinical Role: Consultant Physician, Alfred Hospital
- Research Affiliation: Victorian Heart Institute (VHI)
Dr. Hopper completed her PhD and post-doctoral research fellowship at Monash University’s School of Public Health and Preventive Medicine.
Her research focuses on cardiovascular therapeutics, particularly heart failure, atrial fibrillation, and healthy ageing. She also investigates community-based models of acute care and leads national initiatives in medical device registries, such as the Australian Breast Device Registry. Her work supports UN Sustainable Development Goals related to health and well-being.
Her recent publications reflect a strong trend in clinical trials, patient outcomes, and pharmacological interventions in ageing populations. Key themes include statin therapy in the elderly, device safety surveillance, and barriers to optimal heart failure management.
Scientific Awards and Recognition:
- Dean's Award for Excellence in Research (Early Career), 2019
- ASCEPT Clinical Special Interest Group poster prize, 2013
- Clinical Pharmacology Trainee Prize, 2010
- Abstract ranked top 5 at American Heart Association, 2010
- Clinical Special Interest Group Poster Prize, ASCEPT 2011
Dr. Hopper has secured competitive research grants, including an NHMRC-funded study (STAREE-HEART) and an internal Monash University grant (AWRSG). She mentors early-career researchers and collaborates widely across Australia and internationally. Her work bridges clinical medicine, epidemiology, and health policy.
She is actively involved in public engagement through media contributions, podcasts, and expert commentary on heart disease and medication use in older adults.
